OncoSec Medical Inc. (ONCS) stock starts with “Buy” rating in note to investors by Ci Capital

Ci Capital (OncoSec Medical Inc.: NASDAQ) shares rose on Wednesday Dec 28 with lower trade volume than normal after more analysts initiated coverage on the stock.

Meanwhile, U.S. stocks were little changed on Wednesday, as investors found few reasons to keep pushing shares higher towards the 20,000 mark.

The Dow Jones Industrial Average DJIA, -0.11% rose 3.1 points to 19,949, essentially unchanged on the day. The S&P 500 SPX, -0.39% lost 3 points, or 0.1%, to 2,266 while the Nasdaq Composite Index COMP, -0.59% slipped 6.4 points, or 0.1%, to 5,482.

Analysts at Ci Capital initiated coverage on Ci Capital (OncoSec Medical Inc.: NASDAQ) stock, rating the company at Buy. With a rating of Buy on the shares, the company has a 52-week high of $3.49. A number of other analysts have spoken on the company in recent days, and OncoSec Medical Inc. has secured a consensus one-year price target of $5.33, higher than the opening price of $1.25, a difference of 41.97 percent. Analysts and brokerage firms will subsequently issue periodic updates after initiating coverage,. Price changes targets are not uncommon.

Shares of Ci Capital (OncoSec Medical Inc.: NASDAQ) opened at $1.25 on Tuesday trading between $1.24 and $1.29, and last traded at $1.27, which is a spike of $0.05 or 4.40% over the previous closing price.

Ci Capital (OncoSec Medical Inc.: NASDAQ) currently has a market cap of 25.14M.

Ci Capital (OncoSec Medical Inc.: NASDAQ) Average Daily Trading Volume

The stock’s average daily volume is 183,151 shares out of a total float 18,985,000 and some 54,252 shares traded hands yesterday, below the norm. Look for trading volume to pick up in the coming days as investors often use swings in trading volume to determine substantial volume accumulation or circulation by institutional investors.

As with all potential breakouts, investors look for volume to be at least 40%-50% above normal on the breakout to indicate that fund managers and other professional investors are jumping in.

Institutional sponsorship just refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Professional investors such as these retain substantial teams of analysts researching thousands of stocks, so it is good validation to see them buying a stock you are researching.

Ci Capital (OncoSec Medical Inc.: NASDAQ) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By following the activity of these professional investors and how they affect moving averages,it allows for traders to make more useful decisions on trades.

Trades for Ci Capital (OncoSec Medical Inc.: NASDAQ) have ranged from $1.20 – 3.4900, and the stock now has a 50-day MA of $1.42 and 200-day MA of $1.66. Today’s last price is 63.50%% lower than the 52 week high of $3.49.

Indeed, earnings growth is among the most crucial things to look at in regards to stock investing and, accordingly, investors watch for companies that have raised their earnings at least 25% or more for 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Leave a Reply

Your email address will not be published. Required fields are marked *